Volition RX – Capital Markets Day video
We helped our client Volition RX, a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, to stage their Capital Markets Day by generating a dynamic video presentation.
To see the video, click here
Volition CEO, Cameron Reynolds at the Wall Street Stock Exchange
The presentation focused on new data and the launch and commercial roll out of the company’s first product, the Nu.Q™ Vet Cancer Screening Test, which is on target for a launch this year. The presentation also provided an update on recent 
developments and Volition’s activities, including new and ongoing clinical trials in blood cancer.
Commenting on the event Cameron Reynolds, President and Chief Executive Officer of Volition said, “We were delighted to host a busy virtual capital markets event yesterday and would like to thank all of those that joined the event live. This is an exciting time for the company as we prepare for the launch of the Nu.Q™ Vet Cancer Screening Test later this year. I am equally delighted to share a video of the presentation and Analyst Question and Answer session so that those unable to attend can view in their own time.”
We have been partnering with Volition for several years and work with them to produce their regular financial results.
